BIONCaRT GmbH

Orthopaedic and Joint Cartilage Repair

BIONCaRT GmbH focuses on clinical research in cartilage defects of the knee joint, with interest in restoring damaged articular structures and addressing degenerative or traumatic knee cartilage injury.

  • Knee cartilage damage
  • Articular cartilage regeneration
  • Orthopaedic tissue repair

The sponsor’s research activity is centered on therapies intended for local treatment of knee joint cartilage lesions.

Cell Therapy and Mesenchymal Stromal Cells

The company is involved in clinical investigation of mesenchymal stromal cells derived from umbilical cord tissue, reflecting a therapeutic interest in regenerative cell-based approaches for musculoskeletal repair.

  • Umbilical cord-derived MSC
  • Regenerative cell therapy
  • Cell-based cartilage treatment

This area links cellular medicine with the treatment of focal cartilage injury in the knee.

Regenerative Orthopaedic Biomaterials

Research activity also includes the use of a collagen support structure as part of the therapeutic setting, indicating interest in biomaterial-assisted repair strategies for cartilage restoration.

  • Collagen scaffold
  • Cartilage support matrix
  • Biomaterial-assisted repair

The sponsor’s clinical work connects cellular therapy with structural support for damaged knee cartilage.

Musculoskeletal Regeneration

BIONCaRT’s funded trial activity is concentrated on musculoskeletal regenerative medicine, particularly approaches aimed at improving tissue restoration within the knee joint.

  • Joint tissue regeneration
  • Cartilage restoration
  • Orthopaedic regenerative medicine

The clinical focus remains on therapies for localized structural damage in the knee.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study of BP CC 001 stem cells from umbilical cord tissue for treating knee cartilage damage

    Recruiting

    1 1
    Germany